• Apolipoprotein B, residual cardiovascular risk after acute coronary syndrome, and effects of alirocumabHagström, Emil; Steg, P. Gabriel; Szarek, Michael; Bhatt, Deepak L.; Bittner, Vera A.; Danchin, Nicolas; Diaz, Rafael; Goodman, Shaun G.; Harrington, Robert A.; Jukema, J. Wouter; Liberopoulos, Evangelos; Marx, Nikolaus; Viigimaa, MargusCirculation2022 / p. 657 - 672 https://doi.org/10.1161/CIRCULATIONAHA.121.057807 https://www.scopus.com/sourceid/22581 https://www.scopus.com/record/display.uri?eid=2-s2.0-85137105629&origin=resultslist&sort=plf-f&src=s&sid=de91c20ae4aba03588cc8b0e4d3de083&sot=b&sdt=b&s=AUTHOR-NAME%28viigimaa%29&sl=21&sessionSearchId=de91c20ae4aba03588cc8b0e4d3de083 https://jcr.clarivate.com/jcr-jp/journal-profile?journal=CIRCULATION&year=2022 https://www.webofscience.com/wos/woscc/full-record/WOS:000844880000004
• 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes : developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC)Marx, Nikolaus; Federici, Massimo; Schütt, Katharina; Viigimaa, MargusEuropean Heart Journal2023 / p. 4043-4140 https://doi.org/10.1093/eurheartj/ehad192